|
EMA Urges Fast Action on GMP Failures Found Outside the EU
The European Medicines Agency (EMA) is stressing the need for timely, coordinated communications between EU member states when one state finds out about a drugmaker’s noncompliance with GMPs from a non-EU country’s regulators or from an international organization, such as the World Health Organization.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives